Testosterone, HDL and cardiovascular risk in men: the jury is still out.
"Even when reductions in HDL-cholesterol are observed as a consequence of androgen therapy, the implications for cardiovascular risk modification remain highly uncertain."
Center for Research in Reproduction & Contraception, University of Washington School of Medicine, Seattle, WA, USA and Diabetes & Obesity Center of Excellence, Division of Metabolism, Endocrinology & Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Katya B
KB
Rubinow
Center for Research in Reproduction & Contraception, University of Washington School of Medicine, Seattle, WA, USA.
Stephanie T
ST
Page
HDL; androgens; cardiovascular disease; cholesterol; testosterone